PGR and neoplasm: Our study demonstrates for the first time that the role of FGFR2 in ER+ BCa is dependent on the hormonal background of the tumour and relies on the involvement of the FGF7/FGFR2➔JunB axis in the regulation of PR modulatory effects on ER‐associated cellular events.